FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Digoxin Injection
Status: Currently in Shortage
»Date first posted: 06/04/2021
»Therapeutic Categories: Cardiovascular

Expand all

Covis Pharma (Reverified 04/16/2024)

Company Contact Information:
913-661-3814

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Lanoxin, Injection, 250 ug/1 mL (NDC 70515-260-10)	Available
Lanoxin, Injection, 250 ug/1 mL (NDC 70515-261-10)	Available
Lanoxin, Injection, 100 ug/1 mL (NDC 70515-262-10)	Available
Lanoxin, Injection, 100 ug/1 mL (NDC 70515-263-10)	Available

Hikma Pharmaceuticals USA, Inc. (Revised 04/16/2024)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Digoxin Injection, USP, Injection, .25 mg/1 mL (NDC 0641-1410-35)	Available	Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Sandoz Inc. (Reverified 04/08/2024)

Company Contact Information:
800-525-8747

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 250 ug/1 mL (NDC 0781-3059-95)	Available